CDNA
What one share of Caredx holds
Services – Medical Laboratories
CareDx is a precision medicine company dedicated to improving outcomes for transplant patients and advancing organ health. We deliver solutions designed to empower clinicians and improve patient outcomes. The Company's integrated solutions include non-invasive molecular testing for heart, kidney, and lung transplants; laboratory products; digital health technologies; and patient solutions that support care before and after transplant.
Caredx’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $8.72 |
|---|---|
| Profit | $2.11 |
| Cash and investments | $7.26 |
| Book value | $8.27 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $2.46 | −$2.39 | $0.03 | −$1.03 | — | $0.92 |
| 2017 | $2.07 | −$2.38 | $0.01 | −$0.62 | — | −$0.21 |
| 2018 | $2.15 | −$1.31 | $0.06 | −$0.17 | — | $2.32 |
| 2019 | $3.01 | −$0.52 | — | −$0.07 | — | $2.33 |
| 2020 | $4.13 | −$0.40 | — | $0.72 | — | $5.62 |
| 2021 | $5.67 | −$0.59 | — | −$0.37 | — | $8.80 |
| 2022 | $6.03 | −$1.44 | — | −$0.47 | — | $8.05 |
| 2023 | $5.21 | −$3.54 | — | −$0.34 | — | $5.07 |
| 2024 | $5.90 | $0.93 | — | $0.67 | — | $6.91 |
| 2025 | $7.13 | −$0.40 | — | $0.79 | — | $5.95 |